Corvus Pharmaceuticals, Inc. Made Headway

Mon, Feb 22, 2021 at 05:30 PM
Corvus Pharmaceuticals, Inc. Made Headway

Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) jumped higher at $4.57, representing a gain of 21.5%. The stock got featured on our News Catalysts scanner on Wed 17 Feb 21 at 04:45 PM in the 'PUBLIC OFFERING' category. From Fri 05 Feb 21, the stock recorded 55.56% Up Days and 40.00% Green Days

The stock spiked on Tue 09 Feb 21 at $5.08 with a volume of 2M+.

About Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ)

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.